CALM1 Gene Ventricular Tachycardia Catecholaminergic Polymorphic Type 4 Genetic Test
Components: CALM1 Gene Ventricular Tachycardia Catecholaminergic Polymorphic Type 4 Genetic Test
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Cardiovascular Pneumology Disorders
Doctor: Cardiologist
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for CALM1 Gene Ventricular Tachycardia, Catecholaminergic Polymorphic Type 4 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CALM1 Gene Ventricular Tachycardia, Catecholaminergic Polymorphic Type 4 NGS Genetic DNA Test gene CALM1
Test Details: The CALM1 gene is a gene that codes for the calmodulin protein, which is involved in regulating calcium signaling in cells. Mutations in the CALM1 gene have been associated with various cardiac conditions, including ventricular tachycardia. Ventricular tachycardia is a type of abnormal heart rhythm characterized by rapid and irregular electrical signals in the ventricles, the lower chambers of the heart. It can be life-threatening if not properly managed. Catecholaminergic polymorphic ventricular tachycardia type 4 (CPVT4) is a specific subtype of ventricular tachycardia that is caused by mutations in the CALM1 gene. It is an inherited condition that is typically triggered by physical activity or emotional stress. CPVT4 can be diagnosed through genetic testing, specifically Next-Generation Sequencing (NGS) Genetic Testing. NGS Genetic Testing is a method that allows for the simultaneous sequencing of multiple genes in a single test. It enables the detection of genetic mutations associated with various conditions, including CPVT4. This type of testing can provide valuable information for diagnosis, prognosis, and treatment decisions. If a person has a family history of ventricular tachycardia or other cardiac conditions, or if they have experienced unexplained episodes of rapid heart rate, their healthcare provider may recommend NGS Genetic Testing to check for mutations in the CALM1 gene or other relevant genes associated with ventricular tachycardia. It is important to note that genetic testing should always be conducted and interpreted by qualified healthcare professionals who specialize in genetics and cardiovascular diseases. They can provide appropriate counseling, explain the results, and guide patients and their families in making informed decisions regarding their healthcare.
Test Name | CALM1 Gene Ventricular tachycardia catecholaminergic polymorphic type 4 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Cardiovascular Pneumology Disorders |
Doctor | Cardiologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for CALM1 Gene Ventricular tachycardia, catecholaminergic polymorphic type 4 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CALM1 Gene Ventricular tachycardia, catecholaminergic polymorphic type 4 NGS Genetic DNA Test gene CALM1 |
Test Details |
The CALM1 gene is a gene that codes for the calmodulin protein, which is involved in regulating calcium signaling in cells. Mutations in the CALM1 gene have been associated with various cardiac conditions, including ventricular tachycardia. Ventricular tachycardia is a type of abnormal heart rhythm characterized by rapid and irregular electrical signals in the ventricles, the lower chambers of the heart. It can be life-threatening if not properly managed. Catecholaminergic polymorphic ventricular tachycardia type 4 (CPVT4) is a specific subtype of ventricular tachycardia that is caused by mutations in the CALM1 gene. It is an inherited condition that is typically triggered by physical activity or emotional stress. CPVT4 can be diagnosed through genetic testing, specifically Next-Generation Sequencing (NGS) Genetic Testing. NGS Genetic Testing is a method that allows for the simultaneous sequencing of multiple genes in a single test. It enables the detection of genetic mutations associated with various conditions, including CPVT4. This type of testing can provide valuable information for diagnosis, prognosis, and treatment decisions. If a person has a family history of ventricular tachycardia or other cardiac conditions, or if they have experienced unexplained episodes of rapid heart rate, their healthcare provider may recommend NGS Genetic Testing to check for mutations in the CALM1 gene or other relevant genes associated with ventricular tachycardia. It is important to note that genetic testing should always be conducted and interpreted by qualified healthcare professionals who specialize in genetics and cardiovascular diseases. They can provide appropriate counseling, explain the results, and guide patients and their families in making informed decisions regarding their healthcare. |